Jocelyn Gal

Papers

Total Citations

H-Index

About

Jocelyn Gal is a clinical researcher whose work bridges oncology and advanced radiation technologies, with a particular focus on breast cancer treatment. Her most notable contribution is the phase 2 trial "Robotic Stereotactic Boost in Early Breast Cancer," which explored the use of robotic stereotactic radiosurgery to deliver precise, targeted radiation boosts following whole-breast irradiation. This study, published in 2018, demonstrated the feasibility and safety of this approach, offering a potential pathway to reduce treatment toxicity while maintaining efficacy in early-stage breast cancer patients. Although the paper has accumulated 3 citations, its significance lies in its pioneering methodology, which has informed subsequent investigations into hypofractionated and stereotactic regimens. Gal’s work underscores a commitment to refining radiotherapy techniques, aiming to improve patient outcomes through precision medicine. Her research contributes to the broader effort of personalizing cancer care, particularly in optimizing dose delivery to tumor beds while sparing healthy tissue. For students and researchers, Gal’s study exemplifies how early-phase trials can lay the groundwork for larger, practice-changing studies in radiation oncology.